Welcome to LookChem.com Sign In|Join Free
  • or
2-Furancarboxaldehyde, 5-[4-[[3-bromo-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl] - is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

320337-27-7

Post Buying Request

320337-27-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

320337-27-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 320337-27-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,0,3,3 and 7 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 320337-27:
(8*3)+(7*2)+(6*0)+(5*3)+(4*3)+(3*7)+(2*2)+(1*7)=97
97 % 10 = 7
So 320337-27-7 is a valid CAS Registry Number.

320337-27-7Relevant academic research and scientific papers

CANCER TREATMENT METHOD

-

Paragraph 0152; 0160; 0172, (2016/03/12)

A method of treating cancer is described including administration of a 4-quinazolineamine and at least one other anti-neoplastic agent as well as a pharmaceutical combination including the 4-quinazolineamines.

PHOSPHORUS CONTAINING QUINAZOLINE COMPOUNDS AND METHODS OF USE

-

, (2011/02/24)

Disclosed are novel quinazoline derivatives containing phosphorus substitutions and methods for the treatment of hyperproliferative diseases (e.g. cancer) using the compounds. These compounds are type I receptor protein kinase inhibitors useful in treating disorders related to abnormal protein kinase activities such as cancer and inflammation in mammals. Also disclosed are pharmaceutical compositions containing the compounds, methods for the preparation of the compounds and their pharmaceutically acceptable salts.

Anilinoquinazaolines as protein tyrosine kianse inhibitors

-

Page/Page column 49, (2008/06/13)

Heteroaromatic compounds are described, methods for their preparation, pharmaceutical compositions containing them, methods of use, and their use in medicines. In particular, the invention relates to quinazoline and pyridopyrimidine derivatives which exhibit protein tyrosine kinase inhibition.

CANCER TREATMENT METHOD

-

Page/Page column 49, (2010/02/14)

A method of treating cancer is described including administration of a pyrimidine derivative and a quinazoline derivative as well as a pharmaceutical composition including the same.

Cancer treatment method

-

, (2008/06/13)

A method of treating cancer is described including administration of a 4-quinazolineamine and at least one other anti-neoplastic agent as well as a pharmaceutical combination including the 4-quinazolineamines.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 320337-27-7